Pharmaceutical patent protection: the United States and Japan in comparative perspective

References

• 1 Pallin v. Singer, 36 USPQ 2d 1050 (D. Vt. 1995).
  Google Scholar
• 2 35 U.S.C. § 287(c)(2)(C).
  Google Scholar
• 3 35 U.S.C. § 271 (b) and (c).
  Google Scholar
• 4 Examination Guidelines for Patent and Utility Model in Japan, Part III, Chapter 1 Eligibility for Patent and Industrial Applicability (Main Paragraph of Article 29(1) of the Patent Act).
  Google Scholar
• 5 Tokyo High Court, Hei 12 (Gyoke) No. 65 (2002).
  Google Scholar
• 6 M.P.E.P. § 2111.02.
  Google Scholar
• 7 Examination Guidelines for Patent and Utility Model in Japan, Part III Chapter 2 Section 4 Claims Including Specific Expressions.
  Google Scholar
• 8 Examination Handbook for Patent and Utility Model in Japan, Annex B, Chapter 3 Medicinal Inventions.
  Google Scholar
• 9 Tokyo District Court, Hei 2 (Wa) No. 12094 (1992).
  Google Scholar
• 10 Tokyo High Court, Hei 10 (Gyoke) No. 308 (2000).
  Google Scholar
• 11 Tokyo High Court, Hei 10 (Gyoke) No. 401 (2001).
  Google Scholar
• 12 In re Thorpe, 777 F.2d 695 (Fed. Cir. 1985).
  Google Scholar
• 13 M.P.E.P. § 2113.
  Google Scholar
• 14 Amgen Inc. v. F. Hoffman-La Roche Ltd., 580 F.3d 1340 (Fed. Cir. 2009).
  Google Scholar
• 15 Supreme Court of Japan, Hei 24 (Ju) No. 1204 (2015).
  Google Scholar
• 16 Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. __ (2013).
  Google Scholar
• 17 Mayo Collaborative Serv. v. Prometheus Labs., Inc., 566 U.S. __ (2012).
  Google Scholar
• 18 Alice Corp. Pty. Ltd. v. CLS Bank Int'l, 573 U.S. __ (2014).
  Google Scholar
• 19 2014 Interim Guidance on Patent Subject Matter Eligibility.
  Google Scholar
• 20 M.P.E.P. § 2111.
  Google Scholar
• 21 Examination Handbook for Patent and Utility Model in Japan, Annex B, Chapter 2 Biological Inventions.
  Google Scholar
• 22 Altman D, Sweeney C, Yasui T. Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives. Pharm. Pat. Anal. 3(5), 469–473 (2014).
  CASGoogle Scholar
• 23 M.P.E.P. § 2164.03.
  Google Scholar
• 24 United States v. Telectronics, Inc., 857 F.2d 778 (Fed. Cir. 1988).
  Google Scholar
• 25 Allergan, Inc., v. Sandoz Inc., 796 F.3d 1293 (Fed. Cir. 2015).
  Google Scholar
• 26 M.P.E.P. § 2163.
  Google Scholar
• 27 Falkner v. Inglis, 448 F.3d 1357 (Fed. Cir. 2006).
  Google Scholar
• 28 Examination Guidelines for Patent and Utility Model in Japan, Part III Chapter 2 Section 2 Inventive Step.
  Google Scholar
• 29 Tokyo High Court, Hei 8 (Gyoke) No. 201 (1998).
  Google Scholar
• 30 Tokyo High Court, Hei 15 (Gyoke) No. 104 (2003).
  Google Scholar
• 31 Intellectual Property High Court, Hei 17 (Gyoke) No. 10042 (2005).
  Google Scholar
• 32 35 U.S.C. § 287(c)(2)(A).
  Google Scholar
• 33 Intellectual Property High Court, Hei 17 (Ne) No. 10125 (2006).
  Google Scholar